Safety, censoring, and intent-to-treat analysis: dangers to generalizability.
作者信息
Boulware David R
出版信息
Clin Infect Dis. 2010 Oct 15;51(8):985-6; author reply 987-9. doi: 10.1086/656436.
Abstract
摘要
相似文献
1
Safety, censoring, and intent-to-treat analysis: dangers to generalizability.
Clin Infect Dis. 2010 Oct 15;51(8):985-6; author reply 987-9. doi: 10.1086/656436.
2
Should antiretroviral therapy be delayed for 10 weeks for patients treated with fluconazole for cryptococcal meningitis?
Clin Infect Dis. 2010 Oct 15;51(8):986-7; author reply 987-9. doi: 10.1086/656437.
3
Concerns regarding a randomized study of the timing of antiretroviral therapy in zimbabweans with AIDS and acute cryptococcal meningitis.
Clin Infect Dis. 2010 Oct 15;51(8):984-5; author reply 987-9. doi: 10.1086/656435.
4
Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
Clin Infect Dis. 2010 Jun 1;50(11):1532-8. doi: 10.1086/652652.
5
High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose.
AIDS Res Hum Retroviruses. 2018 May;34(5):399-403. doi: 10.1089/AID.2017.0240. Epub 2018 Feb 26.
6
Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
Clin Infect Dis. 2009 Sep 15;49(6):931-4. doi: 10.1086/605497.
7
Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
BMC Infect Dis. 2005 Aug 24;5:67. doi: 10.1186/1471-2334-5-67.
8
Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?
J Infect. 2005 Aug;51(2):165-71. doi: 10.1016/j.jinf.2005.04.022.
9
Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy.
Int J STD AIDS. 2002 Oct;13(10):724-6. doi: 10.1258/095646202760326516.
10
Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis.
AIDS. 2018 Sep 24;32(15):2259-2261. doi: 10.1097/QAD.0000000000001961.
引用本文的文献
1
Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD009012. doi: 10.1002/14651858.CD009012.pub3.
2
Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.
Expert Rev Anti Infect Ther. 2011 Apr;9(4):415-30. doi: 10.1586/eri.11.21.
本文引用的文献
1
Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
Clin Infect Dis. 2010 Jun 1;50(11):1532-8. doi: 10.1086/652652.
2
Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans.
J Antimicrob Chemother. 2010 Feb;65(2):316-9. doi: 10.1093/jac/dkp451. Epub 2009 Dec 23.
3
Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole.
BMC Infect Dis. 2007 Mar 12;7:14. doi: 10.1186/1471-2334-7-14.
4
Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.
Clin Infect Dis. 1998 Jun;26(6):1362-6. doi: 10.1086/516372.
5
Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe.
Clin Infect Dis. 1998 Feb;26(2):284-9. doi: 10.1086/516298.
Zotero 插件